Alzheimer’s disease and NGF signaling

[1]  P. Yates,et al.  Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. , 2008, Journal of mental deficiency research.

[2]  E. Giacobini,et al.  Cholinergic function and Alzheimer's disease , 2003, International journal of geriatric psychiatry.

[3]  L. Thal,et al.  Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD , 2003, Neurology.

[4]  R. Sulkava,et al.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older , 2003, Journal of neurology, neurosurgery, and psychiatry.

[5]  Yasushi Hiraoka,et al.  Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.

[6]  J. Morrison,et al.  Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer’s disease , 2003, Neuroscience.

[7]  S. Burgess,et al.  Dynein structure and power stroke , 2003, Nature.

[8]  W. Mobley,et al.  Traffic at the intersection of neurotrophic factor signaling and neurodegeneration , 2003, Trends in Neurosciences.

[9]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[10]  W. Kamphorst,et al.  Impaired axonal transport of cortical neurons in Alzheimer’s disease is associated with neuropathological changes , 2002, Brain Research.

[11]  S. Hoyer,et al.  The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review , 2002, Journal of Neural Transmission.

[12]  Philippe P Roux,et al.  Neurotrophin signaling through the p75 neurotrophin receptor , 2002, Progress in Neurobiology.

[13]  E. Sztul,et al.  Hassles with Taking Out the Garbage: Aggravating Aggresomes , 2002, Traffic.

[14]  E. Hol,et al.  Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation , 2002, The Journal of cell biology.

[15]  P. Kelly,et al.  Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis , 2002, The Journal of Neuroscience.

[16]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[17]  G. Livingston,et al.  Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.

[18]  R. Verwer,et al.  Cells in human postmortem brain tissue slices remain alive for several weeks in culture , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  L. Goldstein,et al.  Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.

[20]  B. Lawlor,et al.  Dementia in people with Down's syndrome , 2001, International journal of geriatric psychiatry.

[21]  L. Goldstein,et al.  Disruption of Axonal Transport and Neuronal Viability by Amyloid Precursor Protein Mutations in Drosophila , 2001, Neuron.

[22]  Rüdiger Schweigreiter,et al.  Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system , 2001, Nature Neuroscience.

[23]  M. Gurney,et al.  Human apolipoprotein E4 accelerates β‐amyloid deposition in APPsw transgenic mouse brain , 2001, Annals of neurology.

[24]  Ahmad Salehi,et al.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Mufson,et al.  Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway , 2001, Experimental Neurology.

[26]  R. Brookmeyer,et al.  Aging and the public health effects of dementia. , 2001, The New England journal of medicine.

[27]  J. Day,et al.  Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons , 2001, Journal of neurochemistry.

[28]  J. Howard,et al.  Mechanics of Motor Proteins and the Cytoskeleton , 2001 .

[29]  J. Trojanowski,et al.  Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. , 2000, Molecular biology of the cell.

[30]  I. Tesseur,et al.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.

[31]  C. Hock,et al.  Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease , 2000, European Neurology.

[32]  S. Peiró,et al.  PC12 Cells Have Caveolae That Contain TrkA , 2000, The Journal of Biological Chemistry.

[33]  G. Siegel,et al.  Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain , 2000, Brain Research Reviews.

[34]  D. Moechars,et al.  Acetylcholinesterase-Positive Fiber Deafferentation and Cell Shrinkage in the Septohippocampal Pathway of Aged Amyloid Precursor Protein London Mutant Transgenic Mice , 2000, Neurobiology of Disease.

[35]  Michael W. Miller,et al.  Expression of nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 in the somatosensory cortex of the mature rat: Coexpression with high‐affinity neurotrophin receptors , 2000, The Journal of comparative neurology.

[36]  I. Tesseur,et al.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. , 2000, The American journal of pathology.

[37]  A. Granholm,et al.  Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome , 2000, Experimental Neurology.

[38]  D. Swaab,et al.  P75 Neurotrophin Receptor in the Nucleus Basalis of Meynert in Relation to Age, Sex, and Alzheimer's Disease , 2000, Experimental Neurology.

[39]  S. DeArmond,et al.  Nerve Growth Factor Signaling in Caveolae-like Domains at the Plasma Membrane* , 1999, The Journal of Biological Chemistry.

[40]  M. Hutton,et al.  FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion , 1999, FEBS letters.

[41]  M. Mesulam.  Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles , 1999, Neuron.

[42]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[43]  E. Sztul,et al.  Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪ , 1999, The Journal of cell biology.

[44]  V. Budnik,et al.  The Drosophila β-Amyloid Precursor Protein Homolog Promotes Synapse Differentiation at the Neuromuscular Junction , 1999, The Journal of Neuroscience.

[45]  K. Kawashima,et al.  Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells , 1999, Journal of neuroscience research.

[46]  K. Duff,et al.  Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes , 1999, The Journal of Neuroscience.

[47]  A. Chiba,et al.  Cognitive functions of the basal forebrain , 1999, Current Opinion in Neurobiology.

[48]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[49]  R. Rylett,et al.  NGF-induction of the expression of ChAT mRNA in PC12 cells and primary cultures of embryonic rat basal forebrain. , 1998, Brain research. Molecular brain research.

[50]  D. Swaab,et al.  A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer’s disease , 1998, Neurobiology of Aging.

[51]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[52]  S. Antonarakis.  10 years of Genomics, chromosome 21, and Down syndrome. , 1998, Genomics.

[53]  A. Yang,et al.  Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis , 1998, Journal of neuroscience research.

[54]  L. Acsády,et al.  Expression of nerve growth factor and neurotrophin‐3 mRNAs in hippocampal interneurons: Morphological characterization, levels of expression, and colocalization of nerve growth factor and neurotrophin‐3 , 1998, The Journal of comparative neurology.

[55]  C. Hock,et al.  Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease , 1998, Neuroscience Letters.

[56]  F. Grosveld,et al.  Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. , 1998, Science.

[57]  S A Kuznetsov,et al.  The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Echeverri,et al.  Overexpression of the Dynamitin (p50) Subunit of the Dynactin Complex Disrupts Dynein-dependent Maintenance of Membrane Organelle Distribution , 1997, The Journal of cell biology.

[59]  N. Lavine,et al.  Reduction in p140-TrkA Receptor Protein within the Nucleus Basalis and Cortex in Alzheimer's Disease , 1997, Experimental Neurology.

[60]  H. Hatanaka,et al.  NGF and BDNF increase the immunoreactivity of vesicular acetylcholine transporter in cultured neurons from the embryonic rat septum , 1997, Neuroscience Letters.

[61]  Richard G. W. Anderson,et al.  Tyrosine Kinase Receptors Concentrated in Caveolae-like Domains from Neuronal Plasma Membrane* , 1997, The Journal of Biological Chemistry.

[62]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[63]  E. Mufson,et al.  Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease , 1996, Neuroreport.

[64]  D. Holtzman,et al.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  S. Scott,et al.  Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. , 1996, Brain research. Molecular brain research.

[66]  R. Faull,et al.  Trk receptor alterations in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[67]  P. Dijkhuizen,et al.  Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease , 1996, Neuroscience.

[68]  L. Acsády,et al.  Expression of NGF and NT3 mRNAs in Hippocampal Interneurons Innervated by the GABAergic Septohippocampal Pathway , 1996, The Journal of Neuroscience.

[69]  R. Quirion,et al.  Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  R. Wiley,et al.  Altered NGF protein levels in different brain areas after immunolesion , 1996, Journal of neuroscience research.

[71]  E. Mufson,et al.  Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  K. Davis,et al.  Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.

[73]  N. Lenn,et al.  TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  P. Kochanek,et al.  Upregulation of Nerve Growth Factor Following Cortical Trauma , 1994, Experimental Neurology.

[75]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[76]  M. Fahnestock,et al.  NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. , 1994, Brain research. Molecular brain research.

[77]  F. Sessler,et al.  Neurotrophic factor mRNA expression in dentate gyrus is increased following angular bundle transection , 1994, Brain Research.

[78]  C. Geula,et al.  Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid , 1994, Brain Research.

[79]  D. Anderson,et al.  Expression of trk in MAH cells lacking the p75 low-affinity nerve growth factor receptor is sufficient to permit nerve growth factor-induced differentiation to postmitotic neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[80]  F. Hefti,et al.  Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: Effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration , 1994, Neuroscience.

[81]  R. Ravid,et al.  Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus , 1994, Neuroscience.

[82]  E. Mufson,et al.  Nerve growth factor‐like immunoreactive profiles in the primate basal forebrain and hippocampal formation , 1994, The Journal of comparative neurology.

[83]  M. Barbacid,et al.  Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene , 1994, Nature.

[84]  B. Volk,et al.  Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum , 1994, Neuroscience Letters.

[85]  S. Scott,et al.  Nerve Growth Factor and Alzheimer's Disease , 1994, Reviews in the neurosciences.

[86]  J. Lauterborn,et al.  Nerve growth factor mRNA is expressed by GABAergic neurons in rat hippocampus. , 1993, Neuroreport.

[87]  H. Yeh,et al.  Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[88]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[89]  P. Ernfors,et al.  Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system , 1992, Neuroscience.

[90]  G. Lee,et al.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. , 1992, Journal of cell science.

[91]  J. Conner,et al.  The localization of nerve growth factor‐like immunoreactivity in the adult rat basal forebrain and hippocampal formation , 1992, The Journal of comparative neurology.

[92]  Stanley J. Wiegand,et al.  The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons , 1992, Neuron.

[93]  J. Loeffler,et al.  Promoter Elements of the Rat Choline Acetyltransferase Gene Allowing Nerve Growth Factor Inducibility in Transfected Primary Cultured Cells , 1992, Journal of neurochemistry.

[94]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[95]  D. Holtzman,et al.  Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Steven A. Johnson,et al.  BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.

[97]  A. Björklund,et al.  Loss of AChE- and NGFr-labeling precedes neuronal death of axotomized septal-diagonal band neurons: Reversal by intraventricular NGF infusion , 1991, Experimental Neurology.

[98]  H. Thoenen,et al.  Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis , 1990, The Journal of cell biology.

[99]  L. Olson,et al.  Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family , 1990, Neuron.

[100]  F. Hefti,et al.  Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases , 1989, Neurobiology of Aging.

[101]  F. Gage,et al.  NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat , 1989, Neuron.

[102]  F. Keller,et al.  Nerve growth factor increases in adult rat brain after hypoxic injury , 1989, Neuroscience Letters.

[103]  G. Bloom,et al.  Submolecular domains of bovine brain kinesin identified by electron microscopy and monoclonal antibody decoration , 1989, Cell.

[104]  M. Manthorpe,et al.  Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage , 1988, Experimental Neurology.

[105]  G. Bloom,et al.  Native structure and physical properties of bovine brain kinesin and identification of the ATP-binding subunit polypeptide. , 1988, Biochemistry.

[106]  G. Reynolds,et al.  Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[107]  F. Hefti,et al.  Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[108]  G. Weskamp,et al.  Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septohippocampal pathway in rats , 1986, Brain Research.

[109]  H. Wiśniewski,et al.  Alzheimer's disease in Down's syndrome , 1985, Neurology.

[110]  M. Schwab,et al.  Nerve growth factor increases choline acetyl-transferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons , 1985, Neuroscience.

[111]  M. Schwab,et al.  Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat , 1984, Brain Research.

[112]  L L Iversen,et al.  The retrograde axonal transport of nerve growth factor. , 1974, Brain research.

[113]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[114]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[115]  E. V. van Someren,et al.  Brain aging and Alzheimer's disease; use it or lose it. , 2002, Progress in brain research.

[116]  Raymond Scott Turner,et al.  Animal Model Stable -Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice , 2002 .

[117]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[118]  L. Goldstein,et al.  Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. , 2000, Annual review of neuroscience.

[119]  H. Braak,et al.  Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert , 2000, Acta Neuropathologica.

[120]  K. Meller,et al.  Axonal and dendritic transport in Purkinje cells of cerebellar slice cultures studied by microinjection of horseradish peroxidase , 1999, Cell and Tissue Research.

[121]  D. Swaab,et al.  Neurotrophin receptors in Alzheimer's disease. , 1998, Progress in brain research.

[122]  S. Karki,et al.  The role of the dynactin complex in intracellular motility. , 1998, International review of cytology.

[123]  M. Goedert.  Neurofibrillary pathology of Alzheimer's disease and other tauopathies. , 1998, Progress in brain research.

[124]  T. Arendt,et al.  Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. , 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[125]  M M Mesulam,et al.  The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. , 1996, Progress in brain research.

[126]  R. Feeney,et al.  Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus. , 1991, Neuroscience letters.

[127]  A. Fine,et al.  Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. , 1989, Brain research. Molecular brain research.

[128]  D. Price,et al.  Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. , 1983, Psychopharmacology bulletin.